Your global gateway to faster clinical breakthroughs
Master NMPA regulations. Maximize trial operations. Meet global standards.
Registration for Clinical Trials at ChinaBio™ is now open!
Master China's strategic advantages in global drug development at the Clinical Trials at ChinaBio™ one-day conference
China's clinical edge: Your strategic roadmap
China is a strategic powerhouse for global drug development, delivering complex Phase II/III trials, AI-enabled operations and data quality that supports worldwide registrations. Mastering these advanced operational capabilities in China as the government drives further alignment with wider global standards creates opportunities for significant competitive advantage. Join us at ChinaBio™ Partnering Forum to gain strategic clinical insights and forge partnerships to accelerate your global pipeline.
From protocol strategy and late-stage delivery, to recruitment, data quality and AI enabled operations, hear from the experts on how to successfully design, execute and scale clinical trials in China today.
Master strategic trial design: From regulatory approval to global scalability
Discover how to design clinical protocols that meet NMPA requirements. And, understand how regulatory evolution and protocol decisions interconnect to affect feasibility, timelines and your global pathway success.
Execute complex programs at scale: Patient engagement and late-stage excellence
Unlock practical approaches to achieve consistent recruitment and retention across sites and regions, working with China's diverse patient communities.
Navigate critical partnership decisions: CRO selection and data excellence
Master the strategic choices around Chinese vs global CROs while establishing operational best practices that deliver global-ready data. Explore governance frameworks that ensure quality, speed, and regulatory confidence while building inspection readiness from day one.
Harness technology for competitive advantage: AI-Powered clinical operations
Explore cutting-edge AI applications in data analysis, monitoring, and trial operations for innovative approaches to reduce timelines and improve probability of success.
Define the future standard: China-to-global clinical excellence
Explore how China's evolving clinical trial landscape creates opportunities for domestic innovation and a strong foundation for global development success. Understand the capabilities that will define excellence by 2027 and position your programs to thrive in China's growing market and beyond.
At ChinaBio™ Partnering Forum
Clinical Trials at ChinaBio bridges the gap between clinical execution and business strategy in China's rapidly expanding life sciences market.
This exciting new one-day event takes place before the main ChinaBio™ Partnering Forum begins, delivering the ultimate dual advantage: gain strategic insights to master complex clinical pathways and secure valuable new partnerships to accelerate your pipeline – all in one place.
Who should attend?
Whether you're a China based pharma/biotech company or one evaluating opportunities in China, a CRO staying ahead of the latest clinical research strategies, or a service provider supporting clinical programs, you'll gain strategy-shaping insights from peers who are actively delivering trials within APAC and around the world.
This event is particularly valuable if you're a senior leader, director, or manager responsible for:
• Making strategic decisions about where and how to run trials
• Designing protocols that work within China and across markets
• Ensuring regulatory compliance and data quality
• Managing clinical operations and timelines
• Selecting and managing CROs and vendors
• Evaluating new technologies and AI solutions
• Overseeing procurement and supply chain
• Building capabilities in China or APAC
Explore ChinaBio™ Partnering Forum
Immerse yourself in China's premier life science partnering experience at ChinaBio™ Partnering Forum (April 28–29, 2026)! Join 1,000+ industry leaders for two dynamic days of strategic dealmaking, breakthrough insights, and transformative networking where global healthcare partnerships ignite.
Watch the video to see exactly why Clinical Trials at ChinaBio (April 27, 2026) is the perfect addition to this year's exceptional line-up!
Plus! Expanding the ChinaBio experience in 2026, two additional cutting-edge summits join the program:
- Cell & Gene Therapy Summit at ChinaBio (April 28–29, 2026)
- Antibody & ADC Summit at ChinaBio (April 28–29, 2026)
Four world-class events, one location. Secure your seat today!
FAQs
What is Clinical Trials at ChinaBio?
Clinical Trials at ChinaBio is a specialized one-day forum (April 27,2026) focused on the practical delivery of clinical trials in China's rapidly maturing pharmaceutical market. Taking place ahead of this year's ChinaBio™ Partnering Forum within the same venue, this conference is curated for senior clinical leaders, operators and industry partners - whether based in China or internationally - looking to advance their clinical pipeline in the world's second-largest pharmaceutical market.
The forum addresses the critical shift in China's clinical trials landscape, where delivery quality now defines success as ever-more trials move deeper into Phase II/III studies and broader development pathways spanning local and global markets. Attendees explore how clinical trials are being designed, executed, and scaled in China today.
What Makes It Unique: Clinical Trials at ChinaBio provides experience-led perspectives from industry experts successfully delivering speed, quality, and global confidence in China's evolving clinical landscape. Through panel discussions, fireside chats, and extensive networking opportunities, biopharma professionals will gain actionable strategies to leverage China's advantages in worldwide drug development programs.
Clinical Trials at ChinaBio provides experience-led perspectives from industry experts successfully delivering speed, quality, and regulatory confidence in China's evolving clinical landscape. Through panel discussions, fireside chats, and extensive networking opportunities, biopharma professionals will gain actionable strategies to leverage China's clinical advantages for both domestic market success and worldwide drug development programs.
Taking place on April 27th, the day before ChinaBio™ Partnering Forum (April 28-29,2026), attendees can choose to upgrade their ticket for additional partnering opportunities, one-to-one meetings with 500+ unique companies, and networking with international stakeholders across 30 countries - securing both events at a reduced-rate for maximum value and partnership potential.
When and where is Clinical Trials at ChinaBio taking place?
The Clinical Trials at ChinaBio conference will take place on April 27th, 2026, in Shanghai, China at the venue Kerry Hotel Pudong, Shanghai. You can find out more venue information on the Plan Your Visit page.
What topics will be covered at the event?
The Clinical Trials at ChinaBio conference covers a comprehensive range of topics including:
- Protocol strategy and NMPA regulatory alignment
- Late-stage clinical development and complex program delivery
- Patient recruitment and retention optimization
- Data quality standards for global submissions
- AI-enabled clinical operations and technology integration
- Strategic CRO selection and partnership models
What is the format of the Clinical Trials at ChinaBio event?
- Clinical Trials at ChinaBio (April 27th)
The Clinical Trials at ChinaBio event is a one-day in-person conference taking place on April 27th, 2026, ending with the ChinaBio™ Partnering Forum welcome reception, a shared evening networking reception bringing together the attendees across all 4 co-located events:
Optional add-ons:
Add one of the below events to your Clinical Trials at ChinaBio ticket to extend your event experience for a combined reduced rate:
- ChinaBio™ Partnering Forum (April 28–29, 2026)
- Cell & Gene Therapy Summit at ChinaBio (April 28–29, 2026)
- Antibody & ADC Summit at ChinaBio (April 28–29, 2026)
Will there be opportunities for networking?
Yes, the event is designed to bring together all key stakeholders involved in clinical trials, including sponsors (pharmaceutical/biotech companies), investigators, patients, regulatory agencies, contract research organizations (CROs) and solution providers, providing an excellent opportunity for networking.
The agenda includes interactive panel discussions and engaging fireside chats to open up the conversation, address questions from the audience and stimulate invaluable peer-discussion during networking breaks, helping you connect with like-minded professionals.
Add-on one of the co-located events for full access to extensive Partnering across ChinaBio™ Partnering Forum for a combined event ticket at a reduced price:
- ChinaBio™ Partnering Forum (April 28–29, 2026)
- Cell & Gene Therapy Summit at ChinaBio (April 28–29, 2026)
- Antibody & ADC Summit at ChinaBio (April 28–29, 2026)
Who organizes the Clinical Trials at ChinaBio event?
The congress is organized by Informa Connect, part of Informa PLC. See more of our biotech and pharma events here.
Where can I find the detailed agenda?
The detailed agenda is available to view here.